RxFunction is a wearable technology company with an initial focus on developing and leading a new business segment within the U.S. assistive technology marketplace. The Company’s vision is to improve physical ability for social participation and better living. The company’s first product is walkasins – a wearable sensory prosthesis with the goal to return patients to a lifestyle of confidence and mobility. Walkasins aid in balance improvement, enabling doctors to prescribe a wearable device to patients suffering from balance problems due to peripheral neuropathy.
Privately held and headquartered in Minneapolis, MN, RxFunction has taken assignment of patented technology developed by Co-founder, Dr. Lars Oddsson, as a research professor at Boston University’s Neuromuscular Research Center, and funded privately and supported under grant No. AG040865 awarded by the NIH’s National Institute on Aging.
Walkasins are currently being designed and developed for individuals with peripheral neuropathy who have balance problems. Walkasins have not been submitted to the FDA for review, and are not available for sale at this time.